Skip to main content
. 2023 Apr 8;26(6):106600. doi: 10.1016/j.isci.2023.106600
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies

FAP Abcam ab207178; RRID: AB_2864720
BMI1 Abcam ab126783; RRID: AB_11127730
ABCG2 Abcam ab108312; RRID: AB_10861951
LMO7 Abcam ab224113
MDR1 Cell Signaling Technology Inc 13342; RRID: AB_2631176
NANOG Cell Signaling Technology Inc 4903; RRID: AB_10559205
MPRIP Cell Signaling Technology Inc 14396; RRID: AB_2798472
YAP Cell Signaling Technology Inc 14074; RRID: AB_2650491
pS397YAP Cell Signaling Technology Inc 13619; RRID: AB_2650554
pS109YAP Cell Signaling Technology Inc 46931; RRID: AB_2799315
KLF4 Cell Signaling Technology Inc 4038; RRID: AB_2265207
FAP Santa Cruz Biotechnology sc-65398; RRID: AB_831316
CD45 BD Biosciences clone 30-F11; Cat# 557659, RRID: AB_396774
CD86 BD Biosciences clone GL1; Cat# 560956, RRID: AB_10563076
CD206 BD Biosciences clone MR5D3; Cat# 564668, RRID: AB_2738882
F4/80 BD Biosciences clone T45-2342; 565410, RRID: AB_2687527

Bacterial and virus strains

LV-GV249/FAP/GFP GeneChem Co., Ltd N/A
LV-GV249/GFP GeneChem Co., Ltd N/A

Biological samples

Paraffin tissue section of CRC patients Peking University Cancer Hospital & Institute N/A

Critical commercial assays

CCK-8 Dojido CK04
Bio-Rad SureBeads™ Magnetic Beads Kit Bio-Rad 1614916
RhoA activation assay kit Cytoskeleton BK036
murine tumor dissociation kit Miltenyi Biotec 130-095-929
Proteome Profiler Human Cytokine Array kit R&D Systems, Inc. ARY005B

Experimental models: Cell lines

HCT116 ATCC CCL-247
HCT8 ATCC CCL-244
LS174T ATCC CL-188

Experimental models: mouse

BALB/c-nu mice Beijing HFK Bio-technology Co. Ltd N/A

Oligonucleotides

GAPDH forward 5′- TGCACCACCAACTGCTTAGC-3′ Invitrogen N/A
GAPDH reverse 5′- GGCATGGACTGTGGTCATGAG-3′¢ Invitrogen N/A
FAP forward 5′- GGAAGTGCCTGTTCCAGCAATG -3′¢ Invitrogen N/A
FAP reverse 5′- TGTCTGCCAGTCTTCCCTGAAG -3′¢ Invitrogen N/A
BMI1 forward 5′- AGCAGCAATGACTGTGATGC-3′ Invitrogen N/A
BMI1 reverse 5′-CAGTCTCAGGTATCAACCAG-3′ Invitrogen N/A
ABCG2 forward 5′-CCTGGTGCTCCATGAGGAGAC-3′ Invitrogen N/A
ABCG2 reverse 5′-CAGACTCTGACCTTTTGCCAGG-3′ Invitrogen N/A
SOX2 forward 5′-ACATGAACGGCTGGAGCAAC-3′ Invitrogen N/A
SOX2 reverse 5′-AGGAAGAGGTAACCACAGGG-3′ Invitrogen N/A
OCT4 forward 5′-GACAACAATGAAAATCTTCAGGAGA-3′ Invitrogen N/A
OCT4 reverse 5′-CTGGCGCCGGTTACAGAACCA-3′ Invitrogen N/A
NANOG forward 5′-TGCCTCACACGGAGACTGTC-3′ Invitrogen N/A
NANOG reverse 5′-TGCTATTCTTCGGCCAGTTG-3′ Invitrogen N/A
CTNNB forward 5′-TGATGGAGTTGGACATGGCC-3′ Invitrogen N/A
CTNNB reverse 5′-CTCATACAGGACTTGGGAGG-3′ Invitrogen N/A
KLF4 forward 5′-AAGCCAAAGAGGGGAAGAC-3′ Invitrogen N/A
KLF4 reverse 5′-CATCTGAGCGGGCGAATTTC-3′ Invitrogen N/A
MDR-1 forward 5′-GCCTGGCAGCTGGAAGACAAATAC-3′ Invitrogen N/A
MDR-1 reverse 5′-ATGGCCAAAATCACAAGGGTTAGC-3′ Invitrogen N/A
ABCG2 forward 5′-GGAGGCCTTGGGATACTTTGAA-3′ Invitrogen N/A
ABCG2 reverse 5′-GAGCTATAGAGGCCTGGGGATTAC-3′ Invitrogen N/A
ALDH1 forward 5′-CGGGAAAAGCAATCTGAAGAGGG-3′ Invitrogen N/A
ALDH1 reverse 5′-GATGCGGCTATACAACACTGGC-3′ Invitrogen N/A
ALCAM forward 5′-TCCAGAACACGATGAGGCAGAC-3′ Invitrogen N/A
ALCAM reverse 5′-GTAGACGACACCAGCAACAAGG-3′ Invitrogen N/A
EPHB2 forward 5′-CGCCATCTATGTCTTCCAGGTG-3′ Invitrogen N/A
EPHB2 reverse 5′-GATGAGTGGCAACTTCTCCTGG-3′ Invitrogen N/A
siFAP5′-GAACAATATCCTAGAACAA dTdT -3′ RiboBio Co. Ltd. N/A
siMPRIP5′-GACGGTTCTTCATCCTTTA dTdT -3′ RiboBio Co. Ltd. N/A

Software and algorithms

GraphPad Prism 6.0 software GraphPad Prism Software Inc. https://www.graphpad.com/